MEREO BIOPHARMA GROUP PLC (MREO) Net income 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$41.9MFY2025 · since FY2022: -$42.2M → -$41.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$41.9M | +3.2% |
| FY2024 | -$43.3M | -46.8% |
| FY2023 | -$29.5M | +30.2% |
| FY2022 | -$42.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice